Scientists Unravel More of the Genetic Puzzle Surrounding Lupus
News Oct 27, 2015
Scientists have come closer to understanding the genetic puzzle of lupus after identifying 43 different areas of DNA that contain genetic risk factors which increase the chance of developing the disease.
A research paper, published in Nature Genetics, concludes that it will be very unlikely that any single drug will be completely effective in treating all individuals with lupus; rather a combination of treatments will be required depending on specific cases. It suggests that in future, genetic tests should play an important part in determining which treatments are best targeted in any one individual.
Lupus, or systemic lupus erythematosus (SLE), is an autoimmune disease widely acknowledged as being globally more common than leukaemia, muscular dystrophy and multiple sclerosis. The condition, which is currently incurable, affects approximately 24,700 people in the UK and is genetic in origin. Lupus has an extremely wide range of symptoms and at its most serious it can be fatal, affecting internal organs such as the brain, kidneys or heart.
Professor Tim Vyse, a Principle Investigator for the NIHR Biomedical Research Centre at Guy’s and St Thomas’ and King’s College London said: “Lupus is a very complex disease with a wide spectrum of symptoms but this study has given us a much better idea about which genetic variations increase the risk of developing lupus and the likely effects of these variations.”
The research was funded by Arthritis Research UK in partnership with the George Koukis Foundation and the Wellcome Trust. Arthritis Research UK’s director of research and programmes, Dr Stephen Simpson said: “Understanding the genetic basis of lupus is a crucial step towards improving and managing this painful and debilitating condition. This is the largest study into the genetics of the disease to date, and has shed light on new genes and processes which play a key role in its initiation and progression, so that we can provide better, more appropriate treatment in the future. Arthritis Research UK is the biggest funder of research into lupus in the country and we are committed to helping people live a life free from pain.”
Professor Vyse added: “Despite the progress that we have made there are still a lot of genetic variants that need to be studied further to bring us close to solving the genetic puzzle of lupus. Next, we need to expand the genetic research to include results from studies in non-Europeans. This is particularly important in lupus because it is more common in non-European populations compared with Europeans. We also want to gain more understanding of the effect and the consequences of inheriting different genetic variants that predispose to disease. Such studies will reveal more about what goes wrong in the immune system of those people with this disease.”
CRISPR Diagnostics Could Detect Any Disease on a Paper StripNews
A nucleic acid-detecting diagnostics platform that harnesses the gene editing technology CRISPR was announced today by the newly-launched Mammoth Biosciences, which says the technology could change how we diagnose disease.READ MORE
Feisty Fetal T Cells Can Rebel In UteroNews
Preterm labor, a common pregnancy complication, has long been a mystery to scientists. But a new study shows it may sometimes happen when the fetal immune system “wakes up” too early and begins to reject the mother, causing the uterus to start contracting.READ MORE
Investigating Inflammasomes Implicated in Diabetic RetinopathyNews
Team of researchers employ mouse model exhibiting diabetic retinopathy symptoms that could lead to future translational research studies.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Structural and Molecular Biology 2018
Aug 22 - Aug 23, 2018
Asia Pacific Congress on Probiotics, Prebiotics and Nutrition
Oct 15 - Oct 16, 2018